Taken together, evidence from neuroscience, human research, and clinical practice suggests meaningful overlap between obesity and addiction-related mechanisms. Lorenzo Leggio, MD, PhD, clinical director, National Institute on Drug Abuse, Bethesda, Md
Approved by the FDA in September 2019, Rybelsus offers a promising alternative to those who prefer oral medications over injections
Additionally, GLP-1s have shown potential in helping with addiction and substance dependencies
Ultra-processed foods and cardiovascular disease: analysis of three large US prospective cohorts and a systematic review and meta-analysis of prospective cohort studies
Depending on your insurance plan, you might be able to get Wegovy for free
Telehealth for branded meds : Starts at $39